netFormulary NHS
Cambridgeshire and Peterborough
Formulary
 Search
 Formulary Chapter 2: Cardiovascular system - Full Chapter
Chapter Links...
 Details...
02.06.04  Expand sub section  Peripheral vasodilators and related drugs
Naftidrofuryl
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Amber No SCG

  • Restriced to the treatment of intermittent claudication in people with peripheral arterial disease for whom vasodilator therapy is considered appropriate after taking into account other treatment options as per NICE TA223

 
Link  NICE TA223: Cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
Link  NICE CG147: Peripheral arterial disease - diagnosis and management
Link  Bandolier review of drug treatment of peripheral arterial disease
   
Pentoxifylline (Trental)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red Hospital

  • Pentoxifylline is not recommended for the treatment of intermittent claudication in people with peripheral arterial disease as per NICE TA233

  • NWAFT: Restricted for the treatment of osteonecrosis of the jaw. unlicensed unlicensed

  • Non formulary at all other Trusts and in Primary Care

 
   
 ....
 Non Formulary Items
Cilostazol  (Pletal)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Black

  • Cilostazol, pentoxifylline and inositol nicotinate are not recommended for the treatment of intermittent claudication in people with peripheral arterial disease as per NICE TA233

Link  MHRA: Cilostazol (Pletal) - Risks of cardiovascular and bleeding events
 
Inositol Nicotinate  (Hexopal)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Black

  • Cilostazol, pentoxifylline and inositol nicotinate are not recommended for the treatment of intermittent claudication in people with peripheral arterial disease as per NICE TA233

 
Moxisylyte  (Opilon)

View adult BNF View SPC online View childrens BNF Track Changes
Non Formulary
Grey
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

OTC

Available Over the Counter. Consider Self Care   

Green

Formulary - Can be prescribed in both secondary and primary care.   

Advice

Formulary - Specialist Advice, secondary care advice provided for primary care initiation.  

Amber No SCG

Formulary - Specialist initiation without shared care guidance.  

Amber SCG

Formulary - Specialist initiation with shared care guidance.  

Red Hospital

Restricted - Hospital only, not to be prescribed in primary care.  

Switch

Not recommended for prescribing. Switch to alternative cost-effective option.   

Black

Not recommended for prescribing in primary or secondary care.  

Grey

Not recommended as no formal application made for addition to the formulary. Contact relevant pharmacy team for further information.   

Non Formulary

Non-Formulary (category under review).  

netFormulary